The AHSN Network has benefitted more than 489,000 patients and generated £462 million inward investment for UK economy between April 2020-end of March 2021 new report reveals.
The AHSN Network, has released its Impact Report for 2020-2021.
The report highlights outstanding impacts achieved by AHSNs over the last year and evidences how as a collective we are driving adoption and spread in healthcare innovation, transforming patient outcomes, saving the NHS money, generating economic growth and attracting millions of pounds of investment for the country’s economy.
The AHSN Network response to COVID-19
The report details how in March 2020, the AHSNs quickly realigned activities and resource to support the health and care system’s response to coronavirus.
We quickly refocused our existing work maximising on areas that would provide significant benefits, such as sharing our knowledge of proven technologies and expertise in co-ordinated national spread initiatives.
We also supported new priorities, taking on new programmes of work including a leading role in embedding online consultations in primary care practices; supporting the uptake of remote monitoring and oximetry approaches; dissemination of resources for intensive care units; and supporting the uptake of electronic repeat dispensing to support the primary care workforce.
- 92% of trusts implementing all three key interventions of our tracheostomy programme
- 100% of CCGs in England had launched the national COVID Oximetry @home model by December 2020
- 96% of acute trusts set up virtual ward pathways by March 2021
- More than 21,000 views of collaborative webinars with the RCGP on coronavirus themes for primary care
National adoption and spread programmes
Commissioned by NHS England and NHS Improvement, the AHSNs delivered seven programmes, developed regionally and selected for national adoption and spread during 2018-20. Since moving on to new programmes of national focus, AHSNs have continued work to ensure partners are equipped to sustain these programmes where they are a priority for regional health and care systems.
In 20-21, we launched our new national adoption and spread programmes focusing on major NHS priorities around mental health and cardiovascular disease. Even within this challenging year, these initiatives have added value and delivered impact for the health and care system on a national scale.
In 20-21, 258,000+ patients benefitted from our national adoption and spread programmes. Find out more.
AHSNs host the 15 Patient Safety Collaboratives (PSCs) across England. Commissioned by NHS England and NHS Improvement, the PSCs are vital delivery agents of the national patient safety improvement programmes.
The PSCs realigned resources at the start of the pandemic to support the system to respond in the most critical areas for patient safety, including identifying and managing people at risk of deterioration because of coronavirus and use of early warning and communication tools; and implementing a safer tracheostomy care programme to help hospital staff care for patients with a tracheostomy.
As well as impacts detailed in the earlier AHSN Network response to COVID-19 section, other impacts include:
- 99.3% of all acute and ambulance trusts use the National Early Warning Score (NEWS2)
- 250,000+ views of 14 training films for staff working in care homes who care for residents at risk of deterioration
Supporting innovators and driving economic growth
Funded by the Government’s Ofﬁce for Life Sciences (OLS), our Innovation Exchange is a co-ordinated approach to identify and spread innovations that directly respond to NHS needs, and have the potential to transform the lives of patients. The Innovation Exchange activity supports companies at every stage of their development to encourage economic growth on a regional and national scale.
- £462m investment leveraged
- 700 jobs created and 763 jobs safeguarded
Fast-tracking roll-out of latest technologies
The AHSN Network is a key member of the Accelerated Access Collaborative (AAC), an NHS England and NHS Improvement initiative to remove barriers and accelerate the introduction of groundbreaking new treatments and diagnostics to transform care. We support NHS adoption of transformative technologies and medicines through the AAC’s Rapid Uptake Products (RUP) programmes and MedTech Funding Mandate (MTFM), and until April 2021 through the Innovationand Technology Payment (ITP) programme.
In 20-21, 231,000+ patients benefitted from our delivery of selected AAC products and programmes. Find out more.
Gary Ford, Chair of the AHSN Network and Chief Executive of Oxford AHSN said: “This report demonstrates that as a Network we drive forward results in the most relevant areas to make a real difference for patients and service users, as well as healthcare professionals, innovators and NHS organisations. We use our unique position working across all sectors relevant to health and care and our embedded relationships as a catalyst for the greatest impacts, and this year is a demonstration of how effective that can be.”
Read the full 20-21 AHSN Network Impact Report.